Compare AVT & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVT | MMSI |
|---|---|---|
| Founded | 1921 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.9B |
| IPO Year | 1994 | 1996 |
| Metric | AVT | MMSI |
|---|---|---|
| Price | $60.08 | $73.18 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | $54.33 | ★ $103.56 |
| AVG Volume (30 Days) | ★ 909.3K | 613.9K |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.24% | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | 1.36 | ★ 2.13 |
| Revenue | ★ $22,200,754,000.00 | $1,515,906,000.00 |
| Revenue This Year | $14.21 | $8.78 |
| Revenue Next Year | $5.08 | $5.70 |
| P/E Ratio | $46.02 | ★ $34.50 |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $39.22 | $72.61 |
| 52 Week High | $68.00 | $107.27 |
| Indicator | AVT | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 38.47 | 27.80 |
| Support Level | $49.00 | N/A |
| Resistance Level | $68.00 | $84.91 |
| Average True Range (ATR) | 1.61 | 2.40 |
| MACD | -1.18 | -0.73 |
| Stochastic Oscillator | 2.89 | 12.48 |
Avnet Inc is an electronic component technology distributor and solutions provider. It serves customers from startups and mid-sized businesses to enterprise-level original equipment manufacturers (OEMs), electronic manufacturing services (EMS) providers, and original design manufacturers (ODMs). The group operates in the Electronic Components segment and supports high and medium-volume customers to markets, sells, and distributes electronic components, and the Farnell segment supports lower-volume customers that need electronic components quickly to develop, prototype, and test their products. Its geographic regions are the Americas, EMEA, and Asia.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.